Journals / The Anatolian Journal of Cardiology / 2022 / Cilt: 26 - Sayı: 4

Long-Term Clinical Consequences of Patients Hospitalized for COVID-19 Infection

Pages
305–315
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This should raise awareness among healthcare professionals regarding coronavirus disease 2019 aftercare

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Coronavirus disease 2019, putatively caused by infection with severe acute respiratory coronavirus 2, often involves injury to multiple organs and there are limited data regarding the mid- to long-term consequences of coronavirus disease 2019 after discharge from the hospital.
📊
Key Findings & Data:The study aimed to describe the mid- to long-term conse- quences of coronavirus disease 2019 in hospitalized patients after discharge.
💡
Conclusion & Impact:This should raise awareness among healthcare professionals regarding coronavirus disease 2019 aftercare
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Background: Coronavirus disease 2019, putatively caused by infection with severe acute respiratory coronavirus 2, often involves injury to multiple organs and there are limited data regarding the mid- to long-term consequences of coronavirus disease 2019 after discharge from the hospital. The study aimed to describe the mid- to long-term conse- quences of coronavirus disease 2019 in hospitalized patients after discharge. Methods: This single-center, prospective study enrolled coronavirus disease 2019 patients who were discharged uneventfully from our center. All participants underwent face-to- face interviews by trained physicians and were asked to complete a series of question- naires on third and sixth months’ follow-up visits. Results: A total of 406 consecutive discharged coronavirus disease 2019 patients were enrolled in this study. Patients were divided into 3 groups according to World Health Organization classification as follows: World Health Organization-3 (n = 83); World Health Organization-4 (n = 291); and World Health Organization-5,6 (n = 32). Length of hospital stay was highly, significantly increased in the higher World Health Organization groups (World Health Organization-3 vs. World Health Organization-4, P < .0001; World Health Organization-3 vs. World Health Organization-5,6, P < .0001; World Health Organization-4 vs. World Health Organization-5,6, P < .0001), whereas the length of intensive care unit stay was highly, significantly increased only in World Health Organization-5,6 group compared to other groups (World Health Organization-3 vs. World Health Organization-5,6, P < .0001; World Health Organization-4 vs. World Health Organization-5,6, P < .0001). The most frequent complaints were chest pain (39%), and the frequency of complaints decreased during the 3-6 months follow-up period. Multiple logistic regression analysis indicated that age, coronary artery disease, fibrinogen, C-reactive protein, troponin I, D-dimer, use of steroid and/or low molecular weight hep- arin, and World Health Organization class were found to be independent predictors of ongoing cardiovascular symptoms. Conclusions: The current data demonstrated that persistent symptoms were common after coronavirus disease 2019 among hospitalized patients. This should raise awareness among healthcare professionals regarding coronavirus disease 2019 aftercare

🔖

Cite This Article

ÖZCAN, S., İNCE, O., GÜNER, A., KATKAT, F., DÖNMEZ, E., TUĞRUL, S., ŞAHİN, İ., OKUYAN, E., KAYIKÇIOĞLU, M. (2022). Long-Term Clinical Consequences of Patients Hospitalized for COVID-19 Infection. The Anatolian Journal of Cardiology, Cilt: 26 - Sayı: 4, 305–315. https://ajindex.com/articles/407419

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Tezer H, Deniz M. From asymptomatic to critical illness different clinical manifestations of COVID-19 in Children. Turk J Med Sci. 2021
  2. 51(SI-1):3262-3272. [CrossRef] 2. Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid-19. N Engl J Med. 2020
  3. 383(18):1757-1766. [CrossRef] 3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020
  4. 323(13):1239-1242. [CrossRef] 4. World Health Organization. Clinical management of COVID-19. Available at: https://ww w.who.int/publicatio ns/i/item/clini cal-management-of-covid-19. Accessed 24 August 2021. 5. Motaib I, Zbiri S, Elamari S, Haoudar A, Chadli A, El Kettani C. Cardiovascular risk factors and the severity of COVID-19 dis- ease. Cureus. 2021
  5. 13(6):e15486. [CrossRef] 6. Darcis G, Bouquegneau A, Maes N, et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis. 2021
  6. [CrossRef] 7. Sigfrid L, Cevik M, Jesudason E, et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open. 2021
  7. 11(3):e043887. [CrossRef] 8. Schandl A, Hedman A, Lyngå P, et al. Long-term consequences in critically ill COVID-19 patients: a prospective cohort study. Acta Anaesthesiol Scand. 2021
  8. 65(9):1285-1292. [CrossRef] 9. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018
  9. 39(33):3021-3104. [CrossRef] 10. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016
  10. 37(27):2129-2200. [CrossRef] 11. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management and prevention of chronic obstruc- tive lung disease 2017 report: GOLD executive summary. Respirology. 2017
  11. 22(3):575-601. [CrossRef] 12. https://www.cancer.gov/publications/dictionaries/cancer-term s/def/malignancy. 13. Knuuti J, Wijns W, Saraste A, et al. ESC Guidelines for the d